The frequency of osteoporosis screening in men with inflammatory bowel disease

Area of Science:

• Gastroenterology
• Endocrinology
• Bone Health

Background:

• Osteoporosis is frequently underdiagnosed in men, leading to significant morbidity and mortality from fractures.
• Current guidelines recommend earlier screening and risk assessment for men at high risk of osteoporosis.
• Men with inflammatory bowel disease (IBD) are identified as a high-risk group due to various factors.

Purpose of the Study:

• To investigate the prevalence of corticosteroid use, vitamin D screening, and bone mineral density (BMD) screening in men with IBD.
• To highlight the need for enhanced osteoporosis screening in this specific patient population.

Main Methods:

• Retrospective review of patient data within a gastroenterology practice.
• Analysis of corticosteroid prescription rates.
• Assessment of vitamin D and BMD screening rates among male IBD patients.

Main Results:

• The study population consisted of men diagnosed with inflammatory bowel disease.
• A significant proportion of men with IBD are at high risk for developing osteoporosis.
• Current screening practices for vitamin D and BMD in this cohort require emphasis.

Conclusions:

• Men with inflammatory bowel disease represent a population with a high predisposition to osteoporosis and fragility fractures.
• Routine screening for osteoporosis and assessment of risk factors, including vitamin D levels, should be prioritized in male IBD patients.
• Earlier and more consistent screening can mitigate the risks associated with osteoporosis in this vulnerable group.